Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
The study of the dexamethasone suppression test (DST) in 374 chronic psychiatric patients with concurrent substance dependence, including alcohol, found 97% of nonsuppression associated with affective disorders. The incidence of nonsuppression was 38.5% in major depressive disorder and 27.7% in bipolar affective disorder. This study found no apparent connection between the incidence of nonsuppression and any particular drug group. Predexamethasone plasma concentrations were higher in affective disorders than in other diagnoses. It is concluded that the DST may be of value as part of the clinical approach to the diagnosis of major depressive disorders in a substance-abusing population.
Western Reserve Psychiatric Hospital, Northfield, Ohio 44167.
A A
AA
Olivera
D
D
Fero
J
J
Scibilia
D000328:Adult; D000437:Alcoholism / Q000097:blood / Q000523:psychology; D001714:Bipolar Disorder / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D003866:Depressive Disorder / Q000097:blood* / Q000175:diagnosis / Q000523:psychology; D003907:Dexamethasone; D005260:Female; D006760:Hospitalization; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000523:psychology; D011619:Psychotropic Drugs; D019966:Substance-Related Disorders / Q000097:blood* / Q000523:psychology
D011619:Psychotropic Drugs; D003907:Dexamethasone; D006854:Hydrocortisone